Abstract
Biofilms are among the most important causes of nosocomial and recurrent infections as biofilms confer antibiotic resistance to pathogenic bacteria and protect them from the host’s immune system. Thus, it is imperative to investigate effective therapeutic agents to counteract biofilms. As an important signaling molecule, Nitric Oxide (NO) plays a crucial role in various biological and pathological processes. NO could disperse biofilm and restore the drug sensitivity by reducing intracellular cyclic-diguanosine monophosphate (c-di-GMP) levels. This review highlights recent advances on antibacterial and antibiofilm effects of NO when NO was co-administered with other antimicrobial agents. A significant improvement in drug permeability and biofilm cell targeting and reduced cytotoxicity could be attained with this strategy. In this review, we briefly lay out challenges and propose future directions in this appealing avenue of research on NO-based therapy for biofilm eradication.
Keywords: Nitric oxide (NO), Biofilm eradication, Antibiotic resistance, Bis-(3′-5′)-cyclic-diguanosine monophosphate (c-di- GMP), Antibacterial therapy, Pathogenic infection.
Graphical Abstract
Current Topics in Medicinal Chemistry
Title:The Insights and Perspectives of Nitric Oxide-mediated Biofilm Eradication
Volume: 21 Issue: 24
Author(s): Mingke Yuan, Tao Sun, Jianbing Wu, Yue Fei, Yueqi Yang, Yong Ling, Yihua Zhang and Zhangjian Huang*
Affiliation:
- State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, China Pharmaceutical University, Nanjing210009,China
Keywords: Nitric oxide (NO), Biofilm eradication, Antibiotic resistance, Bis-(3′-5′)-cyclic-diguanosine monophosphate (c-di- GMP), Antibacterial therapy, Pathogenic infection.
Abstract: Biofilms are among the most important causes of nosocomial and recurrent infections as biofilms confer antibiotic resistance to pathogenic bacteria and protect them from the host’s immune system. Thus, it is imperative to investigate effective therapeutic agents to counteract biofilms. As an important signaling molecule, Nitric Oxide (NO) plays a crucial role in various biological and pathological processes. NO could disperse biofilm and restore the drug sensitivity by reducing intracellular cyclic-diguanosine monophosphate (c-di-GMP) levels. This review highlights recent advances on antibacterial and antibiofilm effects of NO when NO was co-administered with other antimicrobial agents. A significant improvement in drug permeability and biofilm cell targeting and reduced cytotoxicity could be attained with this strategy. In this review, we briefly lay out challenges and propose future directions in this appealing avenue of research on NO-based therapy for biofilm eradication.
Export Options
About this article
Cite this article as:
Yuan Mingke , Sun Tao , Wu Jianbing , Fei Yue , Yang Yueqi , Ling Yong , Zhang Yihua and Huang Zhangjian *, The Insights and Perspectives of Nitric Oxide-mediated Biofilm Eradication, Current Topics in Medicinal Chemistry 2021; 21 (24) . https://dx.doi.org/10.2174/1568026621666210701113043
DOI https://dx.doi.org/10.2174/1568026621666210701113043 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Medicinal Chemistry Advancement in Life-Threatening Diseases
The current issue will highlight concise reports that specify ground-breaking insights, including the novel discovery of drug targets and their action mechanism or drugs of novel classes. These are projected to encourage medicinal chemistry future efforts to address the most challenging medical needs. The current issue highlights further efforts to ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neurobiological Underpinnings of the Estrogen - Mood Relationship
Current Psychiatry Reviews Perioperative Safety of Warfarin Therapy and Reversal
Current Drug Safety SnoN in TGF-β Signaling and Cancer Biology
Current Molecular Medicine The Family B1 GPCR: Structural Aspects and Interaction with Accessory Proteins
Current Drug Targets Acyclovir in the Treatment of Herpes Viruses – A Review
Current Medicinal Chemistry Brain Tumor Detection Using Machine Learning and Deep Learning: A Review
Current Medical Imaging Aspartic Proteinases in Disease: A Structural Perspective
Current Drug Targets Sleep Related Disorders in the Elderly: An Overview
Current Respiratory Medicine Reviews Heparin Derivatives as Angiogenesis Inhibitors
Current Pharmaceutical Design Editorial [Hot Topic:Protein targets for development of drugs against Mycobacterium tuberculosis (Guest Editor: Walter Filgueira de Azevedo)]
Current Medicinal Chemistry Aspartic Proteases of Human Pathogenic Fungi are Prospective Targets for the Generation of Novel and Effective Antifungal Inhibitors
Current Enzyme Inhibition Exosomes: A Role for Naturally Occurring Nanovesicles in Cancer Growth, Diagnosis and Treatment
Current Gene Therapy Modification Strategies of Lipid-Based Nanocarriers for Mucosal Drug Delivery
Current Pharmaceutical Design Potassium Channels are a New Target Field in Anticancer Drug Design
Recent Patents on Anti-Cancer Drug Discovery Perspectives in Tissue Microarrays
Combinatorial Chemistry & High Throughput Screening The Immunomodulatory Effects of Physical Activity
Current Pharmaceutical Design Chemistry of the Genus Dorstenia
Current Organic Chemistry The V-ATPase as a Target for Antifungal Drugs
Current Protein & Peptide Science Thiol Proteases: Inhibitors and Potential Therapeutic Targets
Current Medicinal Chemistry The Role of Diabetes in Molecular Pathogenesis of Cancer
Current Signal Transduction Therapy